06
Mar
Q&A with Eric Lefkofsky, CEO of Tempus and Co-founder of Groupon
“Treating a cancer patient without the benefit of modern software is the same as driving at night without headlights”...
24
Jan
Q&A with Susan A. Murphy, Harvard University
Q: Your lab develops experimental trial designs and data analysis methods for increasing the usefulness of mobile health interventions. Can you please give examples how these trials are being used in the areas of substance abuse, physical activity, or helping people quit smoking?...
18
Jan
Q&A with Dr. Dara Richardson-Heron, Chief Engagement Officer, All of Us
Q: Your reputation for passion about engaging and empowering people precedes you. Can you please describe your role at the All of Us Research Program?...
14
Jan
Interview Dawn Barry the new President and Co-founder of LunaDNA
Q: In a sentence, what is Luna DNA going to do?...
02
Jan
Interview with Dr. Frank Lee, Global Healthcare & Life Sciences Industry Leader at IBM; Chief Architect, IBM Reference Architecture for Genomics – Speaker at PMWC 2018 Silicon Valley
Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives? ...
01
Jan
Q&A with Ira Mellman, PhD, Vice President, Cancer Immunology, Genentech – Speaker at PMWC 2018 Silicon Valley
Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?...
28
Dec
Q&A with Matthew Kane, Co-founder & CEO, Precision BioSciences – Speaker at PMWC 2018 Silicon Valley
Q: What are the benefits of the Precision BioSciences’ ARCUS genome editing platform and what makes it unique?...
28
Dec
Q&A with Jon Heimer, CEO, Olink Proteomics – Speaker at PMWC 2018 Silicon Valley
Q: Olink has been rapidly growing its’ library of human protein biomarker assays. What are the popular clinical applications for your biomarker panels?...
25
Dec
Q&A with Peter Donnelly, Director, Wellcome Trust Centre for Human Genetics (Oxford) – Speaker at PMWC 2018 Silicon Valley
Q: How will genomics transform healthcare and how will it impact medicine? Beyond genetics and genomics what other data is relevant and why?...
21
Dec
PMWC Interview with Janusz Dutkowski, Ph.D., Co-founder & CEO, Data4Cure – Speaker at PMWC 2018 Silicon Valley
Q: What are some of the key unique ideas behind the Biomedical Intelligence Cloud? What contextual knowledge do you bring in?...
